IndyGeneUS AI is a black-owned and service disabled veteran-owned and operated small business (SDVOSB) that is driving precision medicine by leveraging data mining and artificial intelligence to expedite the development and manufacturing of quality targeted therapies, bringing them to market faster.
Our mission is to accelerate the discovery, development, and manufacturing of advanced therapeutics to address health disparities that African diaspora populations face in accessing high-quality, equitable health care.
Our goal is to be the #1 CDMO and the global leader in advanced targeted therapy development. Our team of scientific and manufacturing experts will strategically utilize our large-scale manufacturing and comprehensive analytical programs to drive precision therapeutic development.
IndyGeneUS AI is an innovative cell and gene therapy company that's focused on contract development and manufacturing organization (CDMO) based in Washington, DC. Our integrated and comprehensive service offerings provides a one-stop solution to get Advanced Therapies to market faster with exceptional quality. IndyGeneUS AI utilizes a client-driven model paired with a patient-centric culture to deliver high-quality and reliable processes, analytical development, viral vector manufacturing, GMP testing, cell therapy bioprocessing, plasmid production, and cell banking services throughout the entirety of a product’s life cycle.
Optimize processes for cGMP manufacturing of vital vectors at commercial scale and bioprocessing autologous and allogeneic cellular therapies.
Extensive analytical development and testing capabilities for advanced therapeutics and biopharmaceuticals.
From pre-clinical through commercial cGMP, we provide all necessary resources to support gene and cell therapy development.
Offering a full range of Adeno-Associated Viral (AVV) production scales and platforms for research, preclinical, clinical, and commercial manufacturing.
Provide a streamlined and accelerated timeline for the manufacturing of cGMP Master Cell Banks (MCB), Working Cell Banks (WCB), Master Viral Banks (MVB), & Working Viral Banks (WVB).
Our workflow processes and on-site sequencing platforms are aligned to develop and produce innovative advanced therapies in a timely and efficient manner.
IndyGeneUS AI Awarded Grant Funding through QuickFire
IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary GenēUS™ Discovery Platform